Atlanta Precision Oncology Symposium

Breast / Genitourinary / Lung

SATURDAY, FEBRUARY 9, 2019

At the InterContinental Buckhead Atlanta
3315 Peachtree Street NE, Atlanta, GA

REGISTER NOW

Symposium Overview

We invite you to join us for the inaugural Atlanta Precision Oncology Symposium (APOS), a one-day continuing education program that will focus on current approaches to integrating and applying precision medicine into managing patients with breast, lung, and genitourinary cancers. Precision medicine, also known as personalized or individualized medicine, has been a longstanding dream for cancer patients and doctors. The last decade has brought amazing progress on this front. Thanks to the advent of precision medicine and the growing list of targeted therapies that have revolutionized the management of liquid and solid tumors, doctors can now rationally select treatments for cancer patients.

APOS is a pioneering educational program designed to present the complexities of oncology precision medicine in an organized, simplified, friendly fashion, so that they can be understood and properly applied to clinical medicine. Experts in the fields of breast, lung, and genitourinary cancers will share the latest precision medicine advances and practical integration into the clinic. The program will be of interest to those practicing in the context of academia, as well as those in the community oncology environ. Practitioners attending APOS will emerge from the program updated on recent data and armed with new tools to help them integrate precision medicine approaches into their daily clinical practice.


Meet Our Speakers

Rodolfo E. Bordoni, MD

Rodolfo E. Bordoni, MD

Georgia Cancer Specialists, Atlanta, GA
Senthil Damodaran, MD, PhD

Senthil Damodaran, MD, PhD

The University of Texas, MD Anderson Cancer Center, Houston, TX
Maha H. A. Hussain MD, FACP, FASCO

Maha H. A. Hussain MD, FACP, FASCO

Feinberg School of Medicine, Northwestern University Chicago, IL
Benjamin Levy, MD

Benjamin Levy, MD

Johns Hopkins School of Medicine, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial, Baltimore, MD

Christine M. Lovly, MD, PhD

Christine M. Lovly, MD, PhD

Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center Nashville, TN
Lisa Ann Newman, MD, MPH, FASCO

Lisa Ann Newman, MD, MPH, FASCO

Weill Cornell Medicine-New York Presbyterian Hospital Network, New York, NY
Vassiliki Papadimitrakopoulou, MD

Vassiliki Papadimitrakopoulou, MD

University of Texas, MD Anderson Cancer Center, Houston, TX
Daniel Petrylak, MD

Daniel Petrylak, MD

Yale Cancer Center, New Haven, CT

Gregory J. Riely, MD, PhD

Gregory J. Riely, MD, PhD

Memorial Sloan Kettering Cancer Center, New York, NY
Jonathan E. Rosenberg, MD

Jonathan E. Rosenberg, MD

Memorial Sloan Kettering Cancer Center, New York, NY
Joseph A. Sparano, MD

Joseph A. Sparano, MD

Albert Einstein College of Medicine and Montefiore Medical Center, New York, NY
Cheryl Jones, MD

Cheryl Jones, MD

Georgia Cancer Specialists, Atlanta, GA

Katie Lang, M.S.

Katie Lang, M.S.

Kimberly McGregor, M.D.

Kimberly McGregor, M.D.

Director of Medical Affairs, Foundation Medicine, Cambridge, MA
Michelle Glasgow, MD

Michelle Glasgow, MD

Atlanta Gynecologic Oncology, Canton, GA

Conference Schedule

Learning Objectives

  1. Navigate the management of ALK-positive, advanced NSCLC, from targeted to chemo to immunotherapy
  2. Identify emerging biomarkers to maximize the benefit of PD-1/PD-L1 inhibition in lung cancer
  3. Describe targetable MET Exon 14 alterations in progressive, metastatic NSCLC
  4. Identify new patient populations with unique targets in the management of GU malignancies
  5. Discuss how genetics and genomics factor into breast cancer disparities
  6. Identify novel drugable pathways in triple-negative breast cancer
  7. Discuss utilization of a 21-gene expression assay in adjuvant chemotherapy treatment decisions for early-stage breast cancer
  8. Discuss incentives and obstacles to applying precision medicine in the community setting

 

CE Info

This meeting has been planned and will be implemented in accordance with the Essential Areas and Policies of the ACCME. CME, CNE, and pharmacy credit will also be offered.

Venue & Accommodations

InterContinental Buckhead Atlanta

(Conference Venue)
3315 Peachtree Street NE
Atlanta, GA, 30326
Phone: 404-946-9000

Accommodation: Rooms at the Intercontinental

A limited block of rooms has been reserved for APOS at a group rate of $149. Identify yourself as part of the APOS 2019 group when calling reservations.
Reservations: 1-877-834-3613

Meet Our Sponsors

FOUNDING SPONSOR

Diamond Sponsors

DIAMOND

Gold Sponsors

GOLD

Silver Sponsors

Silver

Bronze Sponsors

Bronze

Become a Sponsor

Don't Miss Out!

Conference starts in: